Retatrutide is a synthetic triple-receptor agonist peptide targeting the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) simultaneously, studied extensively across metabolic biology, obesity research, energy expenditure, and cardiovascular science for its unmatched tri-agonist incretin action and superior metabolic influence compared to single and dual-receptor compounds making it the most advanced and broadly acting incretin research peptide currently available in modern metabolic science
Sixth, peptide stability, solubility, and purity are useful laboratory characteristics, but they do not establish human safety, pharmacology, or clinical value
Updated June 20, 2025
105 , dgaa259 (2020)
According to the company, provider response typically takes 24 to 48 hours
This hard shell peptide storage case is designed to securely hold up to 8 standard 3ml vials and 1 larger 10ml vial , with a precision-fit interior that keeps everything in place during transport or storage